Cloris
Lv62
2770 积分
2023-06-15 加入
-
Pathology Findings and In-Life Correlates in the Nonclinical Development of Adeno-Associated Virus (AAV)-Based Retinal Gene Therapies
27天前
已完结
-
Efficacy and safety of efdamrofusp alfa versus aflibercept in participants with neovascular age-related macular degeneration: a randomized, double-masked, active-controlled, non-inferiority, phase 2 trial
1个月前
已完结
-
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration
1个月前
已完结
-
AAV Vector Development, Back to the Future
2个月前
已完结
-
Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application
2个月前
已完结
-
Five-year outcomes of treat and extend regimen using intravitreal aflibercept injection for treatment-naïve age-related macular degeneration
3个月前
已完结
-
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
4个月前
已完结
-
Efficacy and Safety of Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
5个月前
已完结
-
Systemic Toxicity of Recombinant Adeno-Associated Virus Gene Therapy Vectors
7个月前
已完结
-
Adeno-associated virus 9 (AAV9) viral proteins VP1, VP2, and membrane-associated accessory protein (MAAP) differentially influence in vivo transgene expression
7个月前
已完结